Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Multiple Sclerosis Fatigue: early-phase trial registry

1 of 2 indexed Multiple Sclerosis Fatigue trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Multiple Sclerosis Fatigue: 2 US clinical trials tracked, 1 recruiting.

Multiple Sclerosis Fatigue is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Johns Hopkins University, running 2 of these trials.

Enrollment posture brief

Registry condition multiple-sclerosis-fatigue

OPEN 1 | RECR 50% | LATE 0 | EARLY 2 | RANK #7188 | SPON 2

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Multiple Sclerosis Fatig (th…50%
Open-enrollment share among volume-matched conditions near Multiple Sclerosis Fatigue

Multiple Sclerosis Fatigue lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Multiple Sclerosis Fatigue on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Multiple Sclerosis Fatigue is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Top Sponsors

Named interventions

Most-linked intervention names on Multiple Sclerosis Fatigue records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Solriamfetol Drug
1 trials
Midazolam Drug
1 trials
Ketamine Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Multiple Sclerosis Fatigue trials. A trial with sites in several states counts in each.

Maryland 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Multiple Sclerosis Fatigue page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Multiple Sclerosis Fatigue condition card totals 2 registered trials; most-linked intervention Solriamfetol; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.